Key result
Surveillance strategies for soft tissue sarcoma patients must be personalized based on recurrence risk and disease biology, with further research needed to determine their impact on clinical outcomes.
Why the study?
What are the appropriate surveillance strategies for patients with soft tissue sarcoma?
What are the appropriate surveillance strategies for patients with soft tissue sarcoma?
Surveillance for soft tissue sarcoma should include regular clinical assessments and chest X-rays, personalized to the patient's recurrence risk.
Answers are grounded in this paper and cite their sources.
Risk-adapted surveillance merits consideration in soft tissue sarcoma; leaves open effects on outcomes and optimal modalities.
Despite optimal treatment, patients with soft tissue sarcoma are at risk for recurrence and therefore appropriate surveillance is critical. At minimum, regularly scheduled clinical assessments and chest X-rays are necessary. Consensus guidelines are available; however, surveillance strategies must be personalized based on the risk for recurrence and inherent disease biology. Further research is needed on a number of issues, including the impact of surveillance on clinical outcome and the utility of molecular surveillance.
No takes yet. Share an insight, caveat, or question.
Tseng et al. (2014) conducted a review in Soft tissue sarcoma. Surveillance strategies was evaluated. Surveillance strategies for soft tissue sarcoma patients must be personalized based on recurrence risk and disease biology, with further research needed to determine their impact on clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: